Novartis says no job cuts in Cambridge
Swiss drug maker Novartis AG, which unveiled a retrenchment plan on Tuesday that includes eliminating 2,000 positions in the United States and Europe, yesterday said no jobs will be cut at its Cambridge sites, where the company has 2,100 employees. Jeff Lockwood, Novartis’s executive director of communications, said layoffs in the United States will be mostly at the company’s pharmaceutical division. Cambridge is world headquarters of the Novartis Institutes for BioMedical Research, the drug maker’s research and development engine, and also houses a vaccines and diagnostics unit.
For more from BostonGlobe.com, sign up or log in below
To continue, please sign up or log in to BostonGlobe.com
Access the full articles and quality reporting of The Boston Globe at BostonGlobe.com
Sign up
Unlimited Access to BostonGlobe.com for 4 weeks for only 99¢.
Are you a Boston Globe home delivery subscriber?
Get FREE access as part of your print subscription.
BostonGlobe.com subscriber
Click to continue reading this article or to log in to BostonGlobe.com.
